10X Genomics is changing the definition of sequencing by providing an innovative genomics platform that dramatically upgrades the capabilities of existing short read sequencers. The Company does this through a combination of elegant microfluidics, chemistry and bioinformatics. With the 10X Genomics platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/12/15 | $55,500,000 | Series B |
Foresite Capital Paladin Capital Group Venrock | undisclosed |
| 03/17/16 | $55,000,000 | Series C |
Fidelity Management & Research Company Foresite Capital JS Capital Management LLC Paladin Capital Group SoftBank Capital Venrock | undisclosed |
| 01/07/19 | $35,000,000 | Series D Extension |
Fidelity Management & Research Company Meritech Capital Partners  Wells Fargo & Company | undisclosed |
